These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5167423)

  • 1. An accelerated red-cell hemagglutination inhibition immunoassay for measuring fibrinogen degradation products in human serum.
    Fischer R; Furlan M; Beck EA
    Thromb Diath Haemorrh; 1971 Oct; 26(2):311-4. PubMed ID: 5167423
    [No Abstract]   [Full Text] [Related]  

  • 2. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():83-5. PubMed ID: 5290706
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble fibrin and fibrinogen degradation products in rat's blood in Freund's adjuvant-induced experimental polyarthritis].
    Szpilman H; Stachurska J; Kossakowska M; Korościk A; Kopeć M
    Reumatologia; 1972; 10(4):297-302. PubMed ID: 4645478
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antisera to fibrinogen degradation products, fragments D and E].
    Sudo T; Fujisawa M; Okumura H; Manita H
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):652-3. PubMed ID: 4269798
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen-fibrin degradation products in uterine and peripheral blood during Caesarean section.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():1-7. PubMed ID: 4599651
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic studies on drug addiction. I. Antibodies reactive with methadone and their use for detection of the drug.
    Liu CT; Adler FL
    J Immunol; 1973 Aug; 111(2):472-7. PubMed ID: 4197985
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
    Kings GL; Stoodley KD
    Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
    [No Abstract]   [Full Text] [Related]  

  • 12. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific anti-human fibrinogen immune serum. Methods of preparation and specificity determination].
    Ionescu-Stoian F; Ionescu-Dorohoi T; Zilişteanu C
    Arch Roum Pathol Exp Microbiol; 1971; 30(3):449-62. PubMed ID: 5150507
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen-fibrin degradation products during labour and during the puerperium.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():1-6. PubMed ID: 4525174
    [No Abstract]   [Full Text] [Related]  

  • 15. INHIBITION OF THE PRIMARY VACCINIAL LESION AND OF DELAYED HYPERSENSITIVITY BY AN ANTIMONONUCLEAR CELL SERUM.
    PINCUS WB; FLICK JA
    J Infect Dis; 1963; 113():15-21. PubMed ID: 14044087
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of fibrinogen degradation products.
    Cohen RJ
    N Engl J Med; 1970 Dec; 283(26):1465-6. PubMed ID: 5481782
    [No Abstract]   [Full Text] [Related]  

  • 17. [FDP (fibrinogen degradation products) determination by TRCHII (tanned red cell haemogglutination inhibition immunoassay) method].
    Abe K; Endo E; Kato M
    Rinsho Byori; 1971 Aug; 19():Suppl:256. PubMed ID: 5290295
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid sensitive method for measuring fibrinogen split-products in human serum.
    Mertens BF; McDuffie FC; Bowie EJ; Owen CA
    Mayo Clin Proc; 1969 Feb; 44(2):114-20. PubMed ID: 5764792
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid detection of fibrinogen-related antigens in serum.
    Rabaa MS; Bernier GM; Ratnoff OD
    J Lab Clin Med; 1973 Mar; 81(3):476-83. PubMed ID: 4119816
    [No Abstract]   [Full Text] [Related]  

  • 20. [A method of determination of pituitary gonadotropins by means of the hemagglutination inhibition reaction].
    Weiser P
    Zentralbl Gynakol; 1965 Nov; 87(46):1569-73. PubMed ID: 5887313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.